Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues
Biomolecules · 2024
DOI: 10.3390/biom14121482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Jordan M Broekhuis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Polysaccharides, Thyroid Neoplasms, Glycoproteins, Galactose. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Aberrant protein glycosylation is a hallmark alteration of cancer and is highly associated with cancer progression. Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, but the N-glycosylation of its glycoproteins has not been well characterized. In this work, we analyzed multiple freshly prepared PTC specimens along with paired normal tissue obtained from thyroidectomies. Glycomic analyses focused on Asn-linked (N)-glycans and employed mass spectrometry (MS), along with Western blot approaches of total solubilized materials that were examined for binding by specific lectins and a monoclonal antibody (mAb) O6, specific for 3-O-sulfated galactose residues. We observed major differences in PTC versus paired normal specimens, as PTC specimens exhibited higher levels of N-glycan branching and bisection with N-acetylglucosamine residues, consistent with RNAseq data. We also found that 3-O-sulfated galactose was present in N-glycans of multiple glycoproteins from both PTC and control specimens, as recognized by the O6 mAb and as confirmed by MS analyses. These results provide new insights into the N-glycans present in glycoproteins of thyroid cancer and context for further studies of these altered glycans as biomarkers and targets for therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
ORCID-Profile: Rajindra P Aryal, Yasuyuki Matsumoto, Lauren E Pepi, Natalia Chaves, Jorge L Gomez-Mayorga
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NIH HHS
- NIH
- Massachusetts Life Science Center
Zitieren
APA
Broekhuis, J. M., Lu, D., Aryal, R. P., Matsumoto, Y., Pepi, L. E., Chaves, N., Gomez-Mayorga, J. L., James, B. C., & Cummings, R. D. (2024). Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues. Biomolecules. https://doi.org/10.3390/biom14121482
Vancouver
Broekhuis JM, Lu D, Aryal RP, Matsumoto Y, Pepi LE, Chaves N, et al. Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues. Biomolecules. 2024. doi:10.3390/biom14121482
BibTeX
@article{Broekhuis2024,
author = {Broekhuis, Jordan M and Lu, Dongli and Aryal, Rajindra P and Matsumoto, Yasuyuki and Pepi, Lauren E and Chaves, Natalia and Gomez-Mayorga, Jorge L and James, Benjamin C and Cummings, Richard D},
title = {Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14121482}
}
EUVIMED